Literature DB >> 2642944

Both granulocyte-macrophage CSF and macrophage CSF control the proliferation and survival of the same subset of alveolar macrophages.

H S Lin1, B L Lokeshwar, S Hsu.   

Abstract

The effect of granulocyte-macrophage (GM)-CSF on the proliferation of murine pulmonary alveolar macrophages in vitro was investigated. About 20% of freshly isolated alveolar macrophages formed colonies in both liquid and soft agar cultures in the presence of GM-CSF. GM-CSF was also found to be capable of maintaining the survival of these colony-forming cells in vitro. Moreover, GM-CSF could substitute for CSF-1 in maintaining the survival of CSF-1-responding pulmonary alveolar macrophage colony-forming cells in the absence of CSF-1. The concentration of GM-CSF required for maintaining the survival of colony-forming cells without proliferation was much lower than that required for the proliferation of these cells in vitro. It also enhanced the CSF-1-dependent clonal growth of alveolar macrophages. These data suggest that the colony-forming cells that respond to GM-CSF are the same subset of macrophages that form colonies in the presence of CSF-1. GM-CSF did not inhibit the binding of 125I-CSF-1 to alveolar macrophages at 0 degrees C. However, the preincubation of macrophages with GM-CSF at 37 degrees C resulted in a transient down-regulation of CSF-1 binding activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642944

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Macrophage polarization in pathology.

Authors:  Antonio Sica; Marco Erreni; Paola Allavena; Chiara Porta
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

2.  Mechanisms of amphibian macrophage development: characterization of the Xenopus laevis colony-stimulating factor-1 receptor.

Authors:  Leon Grayfer; Eva-Stina Edholm; Jacques Robert
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

3.  Colony-stimulating factor-1-responsive macrophage precursors reside in the amphibian (Xenopus laevis) bone marrow rather than the hematopoietic subcapsular liver.

Authors:  Leon Grayfer; Jacques Robert
Journal:  J Innate Immun       Date:  2013-03-12       Impact factor: 7.349

4.  Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis.

Authors:  Jacek Szeliga; D Sundarsingh Daniel; Ching-Hui Yang; Zvjezdana Sever-Chroneos; Chinnaswamy Jagannath; Zissis C Chroneos
Journal:  Tuberculosis (Edinb)       Date:  2007-10-24       Impact factor: 3.131

5.  Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells.

Authors:  L Churchill; B Friedman; R P Schleimer; D Proud
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

6.  Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing.

Authors:  E Brummer; F Nassar; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types.

Authors:  R Collman; N F Hassan; R Walker; B Godfrey; J Cutilli; J C Hastings; H Friedman; S D Douglas; N Nathanson
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

Review 8.  Role of alveolar macrophages in chronic obstructive pulmonary disease.

Authors:  Ross Vlahos; Steven Bozinovski
Journal:  Front Immunol       Date:  2014-09-10       Impact factor: 7.561

9.  Mycobacterium tuberculosis-induced expression of granulocyte-macrophage colony stimulating factor is mediated by PI3-K/MEK1/p38 MAPK signaling pathway.

Authors:  Jang-Eun Cho; Sangjung Park; Hyeyoung Lee; Sang-Nae Cho; Yoon Suk Kim
Journal:  BMB Rep       Date:  2013-04       Impact factor: 4.778

10.  In vitro production of functional immune cells derived from human hematopoietic stem cells.

Authors:  Witchuda Payuhakrit; Tasanee Panichakul; Natthawut Charoenphon; Panus Chalermsaenyakorn; Adithep Jaovisidha; Chokdee Wongborisuth; Rachanee Udomsangpetch
Journal:  EXCLI J       Date:  2015-09-09       Impact factor: 4.068

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.